Conduit Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $671,992 | $624,861 | $1,076,964 | $654,926 |
Gross Profit | 258,568 | -190 | 249,816 | 244,004 |
EBITDA | -5,143 | -4,780 | -994 | -6,294 |
EBIT | -5,971 | -4,970 | -1,446 | -6,299 |
Net Income | -6,028 | -5,146 | -2,406 | -6,461 |
Net Change In Cash | 671,992 | 624,861 | 1,076,964 | 654,926 |
Free Cash Flow | 56,878 | -24,761 | -3,813 | -2,040 |
Cash | 301,486 | 258,997 | 554 | 71 |
Basic Shares | 40,002 | 2,042 | 2,064 | 2,178 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $922,222 | $0 | $0 | $0 |
Gross Profit | -457 | |||
EBITDA | -15,839 | -324 | -4,887 | -4 |
EBIT | -16,296 | -491 | -3,160 | -488 |
Net Income | -17,802 | -535 | -4,887 | -3,657 |
Net Change In Cash | 922,222 | 0 | 0 | 0 |
Free Cash Flow | -9,733 | -7,725 | -2,266 | -2,151 |
Cash | 554 | 4,228 | 345 | 48 |
Basic Shares | 2,064 | 1,697 | 3,620 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$5.46 |
2025-03-31 | -$19.86 |
2024-12-31 | -$2.15 |
2024-09-30 | -$111.19 |
